Mosaic variegated aneuploidy in development, ageing and cancer

被引:0
|
作者
Malumbres, Marcos [1 ,2 ,3 ,4 ]
Villarroya-Beltri, Carolina [2 ,3 ]
机构
[1] Vall dHebron Barcelona Hosp Campus, Vall dHebron Inst Oncol VHIO, Syst Oncol Program, Canc Cell Cycle Grp, Barcelona, Spain
[2] Spanish Natl Canc Res Ctr CNIO Madrid, Cell Div, Madrid, Spain
[3] Spanish Natl Canc Res Ctr CNIO Madrid, Canc Grp, Madrid, Spain
[4] Catalan Inst Res & Adv Studies ICREA Barcelona, Barcelona, Spain
关键词
SPINDLE ASSEMBLY CHECKPOINT; PREMATURE CHROMATID SEPARATION; Y-CHROMOSOME LOSS; GERMLINE MUTATIONS; CEP57; MUTATION; MITOTIC ARREST; EARLY-ONSET; TRIP13; BUB1; TUMOR;
D O I
10.1038/s41576-024-00762-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Mosaic variegated aneuploidy (MVA) is a rare condition in which abnormal chromosome counts (that is, aneuploidies), affecting different chromosomes in each cell (making it variegated) are found only in a certain number of cells (making it mosaic). MVA is characterized by various developmental defects and, despite its rarity, presents a unique clinical scenario to understand the consequences of chromosomal instability and copy number variation in humans. Research from patients with MVA, genetically engineered mouse models and functional cellular studies have found the genetic causes to be mutations in components of the spindle-assembly checkpoint as well as in related proteins involved in centrosome dynamics during mitosis. MVA is accompanied by tumour susceptibility (depending on the genetic basis) as well as cellular and systemic stress, including chronic immune response and the associated clinical implications.
引用
收藏
页码:864 / 878
页数:15
相关论文
共 50 条
  • [1] Mosaic variegated aneuploidy: Another cytogenetic anomaly with increased cancer risk?.
    Limwongse, C
    Robin, NH
    Schwarz, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A105 - A105
  • [2] Child with mosaic variegated aneuploidy and embryonal rhabdomyosarcoma
    Limwongse, C
    Schwartz, S
    Bocian, M
    Robin, NH
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1999, 82 (01): : 20 - 24
  • [3] High risk of malignancy in mosaic variegated aneuploidy syndrome
    Jacquemont, S
    Bocéno, M
    Rival, JM
    Méchinaud, F
    David, A
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 109 (01): : 17 - 21
  • [4] Microcephaly is not mandatory for the diagnosis of mosaic variegated aneuploidy syndrome
    Callier, P
    Faivre, L
    Cusin, V
    Marle, N
    Thauvin-Robinet, C
    Sandre, D
    Rousseau, T
    Sagot, P
    Lacombe, E
    Faber, V
    Mugneret, F
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2005, 137A (02) : 204 - 207
  • [5] High risk of malignancy in mosaic variegated aneuploidy syndrome
    Hunter, A
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 117A (02): : 199 - 199
  • [6] MOSAIC VARIEGATED ANEUPLOIDY WITH MICROCEPHALY - A NEW HUMAN MITOTIC MUTANT
    WARBURTON, D
    ANYANEYEBOA, K
    TATERKA, P
    YU, CY
    OLSEN, D
    ANNALES DE GENETIQUE, 1991, 34 (3-4): : 287 - 292
  • [7] There is high malignancy risk in mosaic variegated aneuploidy syndrome.
    Jacquemont, S
    Boceno, M
    Genevieve, D
    Rival, JM
    Mechinau, F
    David, A
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 161 - 161
  • [8] Variegated mosaic aneuploidy syndrome in two severely undersized siblings
    Valls, Aina
    Ros, Andrea
    Murillo, Marta
    Garcia, Belen
    Martinez, Daniel
    Maqueda, Elena
    Berrocal, Elena
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 289 - 289
  • [9] A pregnancy with an abnormal heterogeneous karyotype suggestive of mosaic variegated aneuploidy
    Asakura, Keiko
    Maliszewska, C. T.
    Berg, J.
    Pratt, N. R.
    JOURNAL OF MEDICAL GENETICS, 2007, 44 : S113 - S113
  • [10] Mosaic variegated aneuploidy without microcephaly: Implications for cytogenetic diagnosis
    Micale, Mark A.
    Schran, David
    Emch, Sean
    Kurczynski, Thaddeus W.
    Rahman, Nazneen
    Van Dyke, Daniel L.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2007, 143A (16) : 1890 - 1893